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Abstract
As a survival factor for melanocytes lineage cells, MiTF plays multiple roles in development and melanomagenesis.
What role MiTF plays in the DNA damage response is currently unknown. In this report we observed that MiTF was
phosphorylated at serine 73 after UVC radiation, which was followed by proteasome-mediated degradation. Unlike
after c-Kit stimulation, inhibiting p90RSK-1 did not abolish the band shift of MiTF protein, nor did it abolish the
UVC-mediated MiTF degradation, suggesting that phosphorylation on serine 73 by Erk1/2 is a key event after UVC.
Furthermore, the MiTF-S73A mutant (Serine 73 changed to Alanine via site-directed mutagenesis) was unable to
degrade and was continuously expressed after UVC exposure. Compared to A375 melanoma cells expressing wild-
type MiTF (MiTF-WT), cells expressing MiTF-S73A mutant showed less p21
WAF1/CIP1 accumulation and a delayed
p21
WAF1/CIP1 recovery after UVC. Consequently, cells expressing MiTF-WT showed a temporary G1 arrest after UVC,
but cells expressing MiTF-S73A mutant or lack of MiTF expression did not. Finally, cell lines with high levels of MiTF
expression showed higher resistance to UVC-induced cell death than those with low-level MiTF. These data sug-
gest that MiTF mediates a survival signal linking Erk1/2 activation and p21
WAF1/CIP1 regulation via phosphorylation
on serine 73, which facilitates cell cycle arrest. In addition, our data also showed that exposure to different wave-
lengths of UV light elicited different signal pathways involving MiTF.
Background
MiTF plays a critical role in melanocyte lineage differ-
entiation and survival [1], as well as melanomagenesis
[2]. The MiTF gene is amplified in about 20% of mela-
nomas and is capable of transforming normal melano-
cytes in certain genetic environments, therefore it has
been suggested that MiTF can function as an oncogene
[3,4]. However, re-expression of MiTF in BRAF-expres-
sing human melanocytes inhibited cell proliferation,
suggesting that MiTF represses cell cycle progression
[5]. This is consistent with reports showing that MiTF
activates the cyclin-dependent kinase inhibitors
p21
WAF1/CIP1 and p16
INK4A [6,7]. More and more evi-
dence indicates that MiTF plays multiple roles in mela-
nomagenesis including stimulating angiogenesis via
activating Hif1a [8], enhancing cell proliferation via
activating transcription of Bcl-2 and CDK2 [9,10],
preventing apoptosis via activating melanoma inhibitor
of apoptosis (ML-IAP) [11], inhibiting invasion via acti-
vating DIAPH-1 [12], and promoting survival after ele-
vation of cellular reactive oxygen species via activating
Ape/Ref-1 [13]. A recent study using mouse melano-
cytes with various MiTF doses indicated that MiTF
dose was a primary determinant for murine melanocytes
survival after UVR [14]; however, the mechanism(s) by
which this occurred was not clear.
A genetic hallmark of human melanoma is mutually
exclusive mutations of BRAF and NRAS, which are
found in more than 90% of tumors [15]. Oncogenic
BRAF or NRAS mutations activate cell proliferation
pathway through downstream mitogen-activated kinases
Mek1/2 and extracellular signal-regulated kinase (Erk1/
2) [16]. BRAF or NRAS activation leads to Mek1/2 acti-
vation which in turn activates Erk1/2 which directly
phosphorylates MiTF at serine 73 [17,18]. Activated
Erk1/2 can further activate its downstream kinase p90-
RSK1 which can also phosphorylate MiTF at serine 409
[19]. Phosphorylation at both sites triggered by c-Kit
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development [19]. This dual phosphorylation results in a
transient increase of MiTF trans-activation activity and
a subsequent degradation; however, the biological conse-
quence of this transient activation and degradation is
not clear. Recently in vivo studies indicated that muta-
tion at serine 73 completely rescued mouse coat color
[20], suggesting this mutation may have other functions
than melanocyte development, among which participat-
ing in the DNA damage response is one of the possibili-
ties [21]. Whether MiTF plays a role in DNA damage
response has not been previously reported and is the
subject of this study.
In this study, we report that the DNA damaging agent
UVC radiation leads to Erk1/2 mediated phosphorylation
of MiTF at serine 73, which in turn leads to proteasome-
mediated MiTF degradation. Erk1/2 phosphorylation of
MiTF played a critical role in activating p21
WAF1/CIP1
transcription and a temporary G1 cell cycle arrest, which
enhanced cell survival after UVC radiation. These results
suggest a novel function of MiTF in linking Erk1/2 acti-
vation and p21
WAF1/CIP1 regulation after UVC radiation
in normal human melanocytes and melanoma cells.
Results
MiTF is phosphorylated and transiently degraded after
UVC in NHMs and some melanoma cells
To examine whether MiTF plays a role in DNA damage
response, two normal human melanocyte (NHM) cell
lines were exposed to potent DNA damaging agent
UVC (3 mJ/cm
2) and allowed them to recover for var-
ious periods of time. As shown in Fig 1A, MiTF at base-
line was detected as a doublet band on western blot: the
lower band represented unphosphorylated and the top
band the phosphorylated form of MiTF [19]. One hour
after UVC, all the MiTF was shifted to the top band
(Fig 1A). The phosphorylation continued for 2 hours
after UVC, followed by a decrease of MiTF protein
(both forms) at 4 and 6 hours. After that, MiTF protein
started to recover 9 hours post radiation and nearly
completely recovered to its pre-treatment levels 12 to 24
hours after UVC (Fig 1A).
The two NHMs were isolated from neonatal foreskin
of a Caucasian (top) and an African black baby (bottom)
respectively. There was no significant difference in their
response to UVC. A similar response was observed in
c83-2C melanoma cells (Fig 1B). MiTF degradation was
further confirmed by immunofluorescence (Fig 1C). c83-
2C cells were exposed to UVC and fixed for immuno-
fluorescence staining at various time points. Consistent
with its nuclear localization, t h ef l u o r e s c e n c es i g n a lf o r
MiTF was mainly observed in nuclei (Fig 1C). However,
no specific foci were observed, nor was there a dramatic
re-localization of the protein at 1 hour post radiation,
suggesting that phosphorylation of MiTF was not a sig-
nal for recruiting DNA repair proteins to DNA-damage
sites, nor was it a signal for translocation to cytoplasm.
MiTF phosphorylation was examined 1 hour after var-
ious doses of UVC radiation; as low as 1 mJ/cm
2 of
radiation led to MiTF phosphorylation in c83-2C cells
(Fig 1D).
MiTF phosphorylation is via Erk1/2 mitogen-activated
protein kinases (MAPK) and is required for its subsequent
proteasome-dependent degradation
To investigate the upstream signal for MiTF phosphory-
lation, three kinase inhibitors were incubated with
NHMs before they were exposed to UVC (3 mJ/cm
2):
MEK inhibitor U0126 which leads to Erk1/2 inhibition
(10 μM), the p38 MAPK inhibitor SB203580 (20 μM),
and wortamannin (20 μM), an inhibitor of phosphatidy-
linositol-3 kinase, Ataxia telangiectasia mutated (ATM)
and ATM- and Rad3-related (ATR) kinase. Cells were
exposed to UVC (3 mJ/cm
2) and collected 1 hour later
to examine MiTF phosphorylation. As shown in Fig 2A,
top panel, among these kinase inhibitors, only U0126
inhibited UVC-mediated MiTF phosphorylation, sug-
gesting that Erk1/2 is the upstream kinase. This obser-
vation was further confirmed in c83-2C melanoma cells.
The c83-2C cells were pre-treated with U0126 (10 μM),
c-Jun N-terminal kinase inhibitor SP600125 (10 μM),
RSK1/2 inhibitor SL0101 (70 μM) and another Erk1/2
kinase inhibitor PD98059 ((20 μM), and then exposed to
UVC (2.5 mJ/cm
2) and allowed to recover for 1 hour.
Both U0126 and PD98059 inhibited UVC-mediated
MiTF phosphorylation, while SP600125 and SL0101 did
not (Fig 2A, bottom panel). Erk1/2 activation upon
UVC radiation and its inhibition by U0126 was con-
firmed by western blot using phospho-Erk-specific anti-
bodies (Fig 2B).
Next we examined whether the Erk1/2-mediated phos-
phorylation was required for MiTF degradation after
UVC. Pre-treatment with U0126 in c83-2C cells abol-
ished MiTF phosphorylation, as well as its subsequent
degradation (Fig 2C, top panel). A similar result was
also observed in Malme-3 M melanoma cells pre-treated
with U0126 (Fig 2C, bottom panel). These data suggest
that phosphorylation of MiTF by Erk1/2 was necessary
for its degradation.
It was previously reported that the c-Kit signal trig-
gered dual-phosphorylation of MiTF, one at serine 73
by Erk2 and the other on serine 409 by Erk1/2 down-
stream kinase p90 RSK-1. To examine whether UVC
also exhibited a similar effect on MiTF through p90
RSK-1, we pre-treated c83-2C cells with RSK-1 inhibitor
SL0101 before UVC radiation, MiTF degradation was
still observed (Fig 2D), suggesting that p90 RSK-1 phos-
phorylation of MiTF was not a critical event under this
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triggered MiTF phosphorylation and degradation.
Phosphorylation on serine 73 is responsible for
proteasome-mediated MiTF degradation
To confirm that MiTF degradation is mediated by pro-
teasome pathway, c83-2C cells were treated with
MG132, a proteasome inhibitor and then exposed to
UVC. MiTF exhibited an unchanged expression under
these conditions (Fig 3A).
Next we expressed MiTF-WT and MiTF-S73A in
MiTF-negative A375 melanoma cells, and examined
their accumulation after UVC. As shown in Fig 3B,
MiTF-WT showed on western blot as a doublet band,
MiTF-S73A, on the other hand, exhibited a single
band that corresponded to the faster moving band.
MiTF-S73A did not show any band shift nor degrada-
tion after UVC (Fig 3C), while MiTF-WT was phos-
phorylated and degraded (Fig 3D). To investigate
whether poly-ubiquitination is involved in MiTF regu-
lation after UVC radiation, NHMs were exposed to
3m J / c m
2 of UVC and then collected 2 hours later for
immunoprecipitation. As shown in Fig 3E, UVC dra-
matically enhanced poly-ubiquitination of MiTF pro-
tein (compare Lanes 1 and 2). Anti-GFP antibody was
used as a negative control for anti-MiTF antibody
(Lane 3). Taken together, these results suggest that
Erk1/2-mediated MiTF phosphorylation on serine 73 is
required for MiTF degradation after UVC. These
results are consistent with previous observation that
phosphorylation on serine 73 is essential for MiTF
poly-ubiquitination and degradation [22].
Figure 1 MiTF was phosphorylated and degraded after UVC.A ,N o r m a lh u m a nm e l a n o c y t e sw e r ee x p o s e dt o3m J / c m
2 of UVC and
collected at various time points for western blot analysis. NHMs from a white individual (top panel) and a black individual (bottom panel)
showed a similar response. B, human melanoma c83-2C cells were subjected to 3 mJ/cm
2 of UVC and collected for western blot at the indicated
time points. C, c83-2C cells were treated with UVC and fixed at the indicated time and subjected to immunofluorescence detection of MiTF
protein. DAPI staining was used to show nucleus. D, dose-dependent phosphorylation of MiTF in c83-2C cells. In western blot, either p84 or
a-tubulin was used as a loading control.
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enhanced cell survival in A375 cells but expression of
MiTF-S73A did not
Cells normally undergo cell cycle arrest after UVC expo-
sure to allow enough time for DNA damage repair [23].
To investigate the role of MiTF in UVC-mediated DNA
damage response and cell cycle control, A375 cells
which carry a wild-type p53 gene were transfected with
QCXIP-GFP (control vector), QCXIP-MiTF-WT or
QCXIP-MiTF-S73A and then exposed to UVR (3 mJ/
cm
2). Cell cycle distribution was analyzed by fluores-
cence-activated cell sorting at various time points after
staining with Propidium Iodide (PI). About 40% of cells
were in G1 phase when un-irradiated in all three groups.
Eight hours after UVR, G1 population in MiTF-WT-
expressing cells increased to 68% (Fig 4A), while there
were no significant changes in cells expressing MiTF-
S73A or GFP. At 24 hours post radiation, the G1 popu-
lation decreased significantly in all three groups of cells
due to cell death (data not shown). Sub-G1 population
was then quantified. 21.4% of sub-G1 cells were present
in control cells expressing GFP, while only 12.1% of
sub-G1 cells were found in cells expressing MiTF-WT
(Fig 4B). In cells expressing MiTF-S73A, the sub-G1
population was 25.7%, more than 2 fold higher than that
in MiTF-WT-expressing cells and close to what was
observed in control GFP cells (Fig 4B).
The above results suggested that expression of MiTF-
WT caused a temporary G1 arrest after UVC, which
enhanced cell survival. To further confirm this observa-
tion, colony formation assay was used to measure cell
survival rate after UVC. A375 cells were again
Figure 2 MiTF was phosphorylated by Erk1/2 kinase after UVC. A, NHM (top panel) or c83-2C cells (bottom panel) were pre-treated with
various kinase inhibitors and then exposed to UVR at 3 mJ/cm
2, and collected 1 hour post-radiation for western blot analysis. B, UVC-mediated
Erk1/2 activation and U0126 effect on Erk1/2 inhibition was examined by western blot. NHM cells were pre-treated with U0126, exposed to UVC
and collected for western blot 1 hour post-radiation. C, c83-2C cells (top panel) and Malme-3 M cells (bottom) were pre-treated with U0126 and
then subjected to UVR at 3 mJ/cm
2, and collected at the indicated time points for western blot analysis. D, NHM were pre-treated with p90 RSK-
1 inhibitor SL0101 and subjected to UVC, and collected at the indicated time for western blot analysis.
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QCXIP-MiTF-S73A and were irradiated with 3 mJ/cm
2
of UVC 24 hours after transfection. Colonies were
counted 2 weeks later. The relative survival rates were
normalized to that of GFP-expressing control cells and
the results are shown in Fig 4C. MiTF-WT increased
cell survival after UVR, but MiTF-S73A did not.
MiTF-negative melanoma cells are more sensitive to UVC
To investigate whether MiTF confers to a survival
advantage in other melanoma cell lines, we exposed dif-
ferent melanoma cell lines with different MiTF accumu-
lation levels to 3 mJ/cm
2 of UVC and examined the cell
survival 24 hours later by Propidium Iodide staining and
FACS analysis. As shown in Fig 4D, three melanoma
cell lines (A375, 1205Lu and WM3211) which accumu-
lated undetectable MiTF protein [13] showed higher cell
death (19% to 26%) as compared to three MiTF-positive
melanoma cell lines (Malme-3 M, SK-Mel-28 and c83-
2C) (4% to 10%) (Fig 4D and 4E). The difference
between these two groups was significant (two tailed
p value from an unpaired t test is 0.003). To further
confirm that MiTF plays a key role in cell survival after
UVC radiation, MiTF was knocked down in SK-Mel-28
melanoma cell line by 2 different shRNA constructs
Mish1 and Mish2 (Fig 5E); cells were exposed to 2 and
4m J / c m
2 of UVC, and colonies were counted 2 weeks
later. The results indicated that Mish1 and Mish2 trans-
duced cells showed decreased colony formation after
UVC as compared to control parental SK-Mel-28, as
well as SK-Mel-28 cells transduced with pGIPZ empty
vector (Fig 4F).
MiTF participates in G1 arrest via its regulation of
p21
WAF1/CIP1
Because p16
INK4A is often lost in melanoma cells, we
examined accumulation of CDK inhibitors p21
WAF1/CIP1
and p27
KIP1, both of which are downstream of MiTF.
MiTF directly activates p21
WAF1/CIP1 expression and
indirectly activates p27 [6,12]. The basal level of p27
KIP1
was not significantly altered in these three groups of
cells (Fig 5A). However, p21
WAF1/CIP1 level was elevated
in cells expressing MiTF-WT as compared to cells
expressing MiTF-S73A, which showed a slightly elevated
level of p21
WAF1/CIP1 as compared to cells expressing
GFP (Fig 5A).
To confirm that the regulation of p21
WAF1/CIP1 by
MiTF was indeed via transcriptional regulation, mRNA
from A375 cells expressing MiTF-WT, MiTF-S73A and
GFP was isolated and p21
WAF1/CIP1 mRNA level deter-
mined by quantitative RT-PCR. As shown in Fig 5B,
MiTF-WT increased p21
WAF1/CIP1 mRNA to about
5 fold that in control GFP-expressing cells, while MiTF-
S73A also increased p21
WAF1/CIP1 mRNA to about
Figure 3 MiTF phosphorylation on serine 73 by Erk1/2 kinase
was required for its proteasome-mediated degradation after
UVR. A, c83-2C cells were exposed to UVC in the presence of
MG132 and collected for western blot analysis at the indicated time
points. B, transient expression of MiTF-WT, MiTF-S73A in A375
melanoma cell line. C83-2C cells served as a positive control for
MiTF western blot. GFP is the control cells transfected with GFP in
the same QCXIP vector that carried MiTF-WT or MiTF-S73A coding
sequence. C, Cells expressing MiTF-S73A were exposed to UVC and
collected for western blot analysis. D, Cells expressing MiTF-WT were
exposed to UVC and collected for western blot analysis. E, MiTF was
poly-ubiquitinated after UVC radiation. NHMs were exposed to UVC
(3 mJ/cm
2) and collected for immunoprecipitation by anti-MiTF
antibodies (un-irradiated cells and anti-GFP antibodies were used as
controls), then probed with anti-ubiquitin antibodies (top panel).
The membrane was stripped and blotted with anti-MiTF antibodies
for a loading control (bottom). The IgG label indicates antibody
heavy chain of IgG proteins.
Liu et al. Molecular Cancer 2010, 9:214
http://www.molecular-cancer.com/content/9/1/214
Page 5 of 122f o l do ft h a ti nc o n t r o lc e l l s .M i T Fe x p r e s s i o nl e v e l s
were also examined in these cells by qRT-PCR. The
control A375 GFP cells expressed very low levels of
MiTF, nearly undetectable, which is consistent with our
previous observation that no MiTF protein was detect-
able in A375 cells. In cells transfected with either MiTF-
WT or MiTF-S73A constructs the mRNA of MiTF
accumulated to approximately 90 fold that in control
cells. To further confirm that this regulation is via dif-
ferential transcriptional activities on the p21
WAF1/CIP1
promoter, MiTF-WT or MiTF-S73A constructs were
co-transfected with p21
WAF1/CIP1 promoter-luciferase
reporter plasmid. We observed that expression of MiTF-
WT led to about 2 fold of p21
WAF1/CIP1 promoter activ-
ity as compared to expression of MiTF-S73A mutant
(Fig 5C). Further more, treating the NHMs with U0126
Figure 4 Expression of MiTF-WT enabled a temporary G1 arrest for improving cell survival after UVR. A, A375 cells were transfected with
GFP, MiTF-WT or MiTF-S73A and then exposed to UVC at 3 mJ/cm
2, and fixed 8 hours later for FACS analysis after Propidium Iodide staining. B,
sub-G1 population of cells treated in A were calculated by FACS analysis and graphed 24 hours after UVC treatment. C, cells in A were seeded
and exposed to UVC, then incubated for colony formation assay. Colonies formed 2 weeks after were counted, normalized to that in GFP-
expressing cells and graphed. D, A375, WM3211, 1205Lu, Malme-3 M, SK-Mel-28 and c83-2C cells were exposed to UVC at 3 mJ/cm
2, and cells
were then collected 24 hours later for FACS analysis. E, Percentage of cell death before and after UVC were calculated and graphed F,
knockdown of MiTF decreased cell survival after UVC. MiTF was knocked down by Mish1 and Mish2 shRNA (see Fig 5E) and exposed to 3 mJ/
cm
2 of UVC. Colony formation was analyzed about 2 weeks post-radiation.
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which was concomitant with reduced p21
WAF1/CIP1 pro-
tein levels (Fig 5D). To further confirm regulation of
p21
WAF1/CIP1 by MiTF, MiTF was knocked down in SK-
Mel-28 cells by lentivirus mediated shRNA Mish1 and
M i s h 2( 2d i f f e r e n ts h R N Ac o n s t r u c t s ) .A ss h o w ni nF i g
5E, both shRNA knocked down MiTF to about 30% of
its original protein levels (Fig 5E, right panel), the con-
trol lentivirus vector GIPZ did not affect MiTF expres-
sion. Both p21
WAF1/CIP1 mRNA and protein levels
decreased when MiTF was knocked down (Fig 5E). A
known MiTF target Bcl2 protein accumulation was also
Figure 5 MiTF-S73A is less potent in activating p21
WAF1/CIP1 transcription.A ,p 2 1
WAF1/CIP1 and p27
KIP1 protein accumulation in A375 cells
expressing MiTF-WT, MiTF-S73A and GFP were analyzed by western blot. B, transcripts of p21
WAF1/CIP1 and MiTF were analyzed by qRT-PCR in
the above cells, a-tubulin was the reference for both genes. C, p21
WAF1/CIP1 promoter reporter analysis in cells co-transcfected with MiTF-WT or
MiTF-S73A mutant constructs. D, p21
WAF1/CIP1 protein accumulation decreased when MiTF phosphorylation was inhibited. NHMs were treated
with 20 μM of U0126 for 24 hours and collected for western blot analysis. E, knockdown MiTF led to decreased p21
WAF1/CIP1 expression.
Quantitative RT-PCR (left) and western blot (right) analysis of p21
WAF1/CIP1 expression in control SK-Mel-28 cells (Mel-28), cells transduced with
empty lentivirus vector pGIPZ (GIPZ), and cells transduced with lentivirus carrying MiTF shRNA constructs (Mish1 and Mish2). Again a-tubulin was
used as a loading control. F, top: p27
KIP1 protein accumulation after UVC in A375 cells expressing MiTF-WT, MiTF-S73A and GFP; bottom:
p21
WAF1/CIP1 protein accumulation after UVC in A375 cells expressing MiTF-WT, MiTF-S73A and GFP. The p53 served as a positive control for UVC
radiation, a-tubulin served as a loading control. The western was repeated three times and a representative blot is shown; G, the p21 protein
levels in the western blot were quantified by a densitometry, normalized to a-tubulin levels and then normalized to that in cells without
irradiation and graphed. H, qRT-PCR analysis of p21
WAF1/CIP1 mRNA accumulation after UVC in A375 cells expressing MiTF-WT or MiTF-S73A.
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which may help to explain in part why MiTF knock-
down led to decreased cell survival after UVC (Fig 4F).
Next we examined the kinetics of p21
WAF1/CIP1 and
p27
KIP1 after UVC. The p27
KIP1 protein showed a rapid
degradation after UVC in all cells examined and no dif-
ference was observed in these three groups of cells (Fig
5F, top panel), suggesting that p27
KIP1 was not responsi-
ble for the observed temporary G1 arrest in MiTF-WT-
expressing cells. The p21
WAF1/CIP1 protein degraded
transiently after UVC as previously reported [24] at 2 to
4 hours, and followed by a rapid re-accumulation (Fig
5F, bottom panel). In cells expressing MiTF-WT pro-
tein, p21
WAF1/CIP1 degraded to less than 20% of its origi-
nal level 2 to 4 hours post-UVC and recovered to about
50% at 8 hour, over 60% at 12 hour. In cells expressing
MiTF-S73A protein, p21
WAF1/CIP1 also degraded 2 to
4 hours post UVC; however, at 8 and 12 hour post
radiation, it remained at 25% and 42% of that in
untreated cells, respectively. Note that the p21
WAF1/CIP1
level in MiTF-S73A-expressing cells was already lower
than that in MiTF-WT cells. This slower recovery of
p21
WAF1/CIP1 may also result from less effective activa-
tion of p21
WAF1/CIP1 by MiTF-S73A mutants. The
p21
WAF1/CIP1 protein level showed a similar slower
recovery in control cells expressing GFP (Fig 5F, bottom
panel). The kinetics of p21
WAF1/CIP1 protein levels from
these western blots were quantified by a densitometer
and normalized to the untreated cells, and graphed in
Fig 5G. The kinetics of p21
WAF1/CIP1 mRNA following
UVC radiation was determined by qRT-PCR, normalized
to a-tubulin mRNA, and the results are shown in Fig
5H. Interestingly, the mRNA levels of p21
WAF1/CIP1
remained basically unchanged during the first 4 hours of
recovery, but then it was induced dramatically and
rapidly in MiTF-WT cells but to a lesser extend in
MiTF-S73A cells (Fig 5H).
Differential response of MiTF to different wavelengths of
UV radiation
Although UVC is a strong carcinogen and elicits a dis-
tinct DNA damage response, UVA and UVB are more
directly relevant to melanomagenesis. A large amount of
data indicates that these different wavelengths of UV
radiation each triggers different signaling cascades upon
radiation [25]. We examined how MiTF responded to
UVA and UVB radiation. After UVA radiation, MiTF
was degraded 4 to 6 hours after radiation without a dis-
tinct phase of phosphorylation (Fig 6A, top panel).
MiTF protein was restored to its pre-radiation level 9
hours after radiation. The p53 protein accumulation
increased from 4 hours post-radiation and served as a
positive control for the treatment. The bottom panel of
Fig 6A shows the dose-dependent degradation of MiTF
4 hours post-radiation. This degradation was not inhib-
ited by U0126 (Fig 6B), suggesting that there were dis-
tinct signal transduction pathways involved in MiTF
regulation after UVC and UVA radiation. To further
understand this difference, we examined Erk1/2 activa-
tion 1 hour after UVA radiation. In fact Erk1/2 did not
show substantial activation at this time (Fig 6C). In con-
trast, MiTF did not exhibit any changes in terms of
accumulation levels or phosphorylation status after UVB
radiation (Fig 6D). 25 mJ/cm
2 of UVB did not affect
MiTF accumulation or phosphorylation up to 24 hours
( F i g6 D ,t o pp a n e l ) ;U pt o7 5m J / c m
2 of UVB radiation
did not trigger MiTF phosphorylation at 1 hour after
radiation (Fig 6D, bottom panel). As a positive control,
p53 up-regulation was observed (Fig 6D).
Discussion
MiTF is a lineage-specific transcription factor; how it is
regulated after DNA damage has not been reported,
although it was evident that MiTF dose was correlated
with cell survival after UVR [14]. Here we show that the
action of MiTF was downstream of Erk1/2 kinase and
that phosphorylation on serine 73 played a key role in
its trans-activation activity on p21
WAF1/CIP1 promoter
under these conditions. The Erk1/2 phosphorylation led
to proteasome-mediated MiTF degradation, which was
concomitant with a temporary G1 cell cycle arrest.
Although it was previously known that both Erk1/2 and
p21
WAF1/CIP1 was activated by UVC [26], a direct link
between these two factors was not elucidated. Our data
suggest that MiTF participates in G1 cell cycle arrest
after UVC via Erk1/2 kinase and p21
WAF1/CIP1 regula-
tion, and hence provides a direct link between Erk1/2
kinase and p21
WAF1/CIP1 activation.
It was previously reported that Erk2 directly phos-
phorylated MiTF at serine 73 [18], and this phosphory-
lation occurred under the condition of c-Kit stimulation,
which also triggered a second phosphorylation on serine
409 by p90 RSK-1, leading to a transient increase of its
trans-activation activity and subsequent proteasome-
mediated MiTF degradation [19]. We observed that
under UVC stress, inhibition of Mek1/2 kinase activity
led to MiTF stabilization while inhibition of p90 RSK-1
activity did not, suggesting that phosphorylation on ser-
ine 73 was the key signaling event after UVC. This was
further confirmed by MiTF-S73A mutation which was
not degraded after UVC. The degradation was inhibited
by proteasome inhibitor MG132, suggesting that the sig-
naling pathways via Erk1/2 activation after UVC and
after c-Kit stimulation were distinct from each other.
We observed that re-expression of MiTF-WT in the
A375 melanoma cell line restored a temporary G1 arrest
after UVC, while control cells expressing GFP or MiTF-
S73A cells did not, suggesting that degradation of MiTF
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therefore allow DNA repair and enhance cell survival. In
fact we observed that cells expressing MiTF-WT showed
better overall survival after UVC. Although MiTF-S73A
mutant was present constantly after UVC, it was unable
to trigger the G1 arrest. As our data shows, part of the
reason may be the weak activation on p21
WAF1/CIP1 pro-
moter by this mutant. However, it is also possible that
there are other downstream genes differentially regu-
lated by MiTF-WT and MiTF-S73A, therefore affecting
the cell cycle progression.
The temporary G1 arrest mediated by MiTF-WT
seemed to enhance cell survival after UVC, as the cell
death was decreased to about half of that in cells
expressing MiTF-S73A or control GFP protein. This
result was further confirmed in different melanoma cell
lines expressing different levels of MiTF. Cell lines with
high levels of MiTF accumulation survived better than
cells with lower or un-detectable level of MiTF. This
result is consistent with a recent finding that MiTF dose
was correlated with cell survival after broad-band UV
radiation [14].
As a tumor suppressor playing versatile roles in many
aspects of cell cycle progression and DNA replication,
p21
WAF1/CIP1 is subjected to regulation of multiple tran-
scription factors including p53, Rb, c-Myc and MiTF
[6,27,28]. While it is well established that p21
WAF1/CIP1
inhibits CDK activities and therefore inhibits cell cycle
progression, p21
WAF1/CIP1 is also important for DNA
replication initiation by binding to proliferating cell
nuclear antigen (PCNA) [29,30]. Therefore the precise
role of p21
WAF1/CIP1 in cell cycle progression is more
complicated and remains to be clarified. In A375 mela-
noma cell lines we observed a transient degradation of
p21
WAF1/CIP1 and then a rapid recovery of this protein
12 hours after UVC. The early degradation event may
serve the purpose of releasing PCNA from replication
fork [31] and therefore initiating a G1 arrest, and the
subsequent recovery may serve the purpose of inhibiting
CKD activities for further maintaining the G1 arrest.
CDK inhibitor p27
Kip1 usually increases when cell cycle
is arrested in G1 phase [32], yet in our experiment we
observed that p27
Kip1 degraded 8 to 12 hours post-UVC
radiation. Intriguingly, while p21
WAF1/CIP1 was degraded
rapidly 2 to 4 hours post-radiation, p27
Kip1 maintained a
relatively unchanged level (Fig 5F); when p27
Kip1 was
degraded 8 hours post-radiation, p21
WAF1/CIP1 levels
started to restore. It seems these two CDK inhibitors
are orchestrated to ensure a G1 arrest in MiTF-
expressed A375 cells.
Previously we showed that MiTF was temporarily
degraded after elevation of cellular reactive oxygen
Figure 6 Distinct responses of MiTF to UVA and UVB radiation. A, NHMs were exposed to UVA (2.5 J/cm
2) and collected for western blot at
the indicated time points (top panel) or 4 hours post-UVA at various doses (bottom panel). The p53 serves as a positive control and p84 or
a-tubulin serve as loading controls. B, NHMs were pre-treated with U0126 and then exposed to UVA and collected for western blot analysis at
the indicated time points. C, No obvious Erk1/2 activation after UVA radiation. NHM was irradiated with either UVA (2.5 J/cm
2) or UVC (3 mJ/
cm
2) and collected for western blot analysis 1 hour post-radiation. D, NHMs were exposed to UVB (25 mJ/cm
2) and collected for western blot at
the indicated time points (top panel) or 1 hour post-UVB at various doses (bottom panel). Again the p53 serves as a positive control and a-
tubulin serve as a loading control.
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Erk1/2 kinase. Considering that both UVC and ROS
causes similar DNA damages and therefore may employ
similar repair pathways [33], the Erk1/2-mediated phos-
phorylation and degradation of MiTF may reflect a gen-
eral mechanism of MiTF-mediated survival pathways
which is outlined in Fig 7. Upon UVR or ROS stress,
MAP kinase is activated which leads to phosphorylation
of MiTF on serine 73 and subsequent degradation of
MiTF protein. The temporary degradation was corre-
lated with a temporary G1 cell cycle arrest, correspond-
ing with p21
WAF1/CIP1 degradation and re-activation,
which allows sufficient time for DNA damage repair and
ensure of a better cell survival (Fig 7).
In response to UVB radiation, MiTF levels were not
changed at the examined dose and time range, nor its
phosphorylation status (Fig 6D). However, MiTF was
degraded without obvious band shifting after UVA treat-
ment (Fig 6A). Pre-treatment with U0126 also did not
prevent MiTF degradation after UVA radiation, suggest-
ing that after UVA MiTF was not phosphorylated by
Erk1/2 kinase, nor was the degradation mediated by
phosphorylation. These data indicate that signaling path-
ways after UVA, UVB and UVC are different, which is
consistent with previous observations that different
wavelengths of UV light trigger different cellular
responses [34]. The UVA-MiTF signaling pathway is
still under intensive investigation in our laboratory.
Conclusions
In summary, our data indicated that MiTF played an
active role in response to UVC radiation by directly
linking Erk1/2 and p21
WAF1/CIP1 activation. Erk1/2
kinase is downstream of BRAF and NRAS pathways,
which are frequently mutated in human melanomas
[35]. Recently it was reported that the MiTF pathway
was also frequently mutated in human melanomas
[36-38]. Taken together, mutations in these pathways
may compromise the cellular defense mechanisms
against UV-mediated DNA damage and therefore
increase the genome instability, eventually leading to
melanomagenesis.
Methods
Cell lines and cell culture
Normal human melanocytes were isolated from new-born
foreskin followed the procedure by Eisinger and Marco
[39], and cultured in MCDB153 medium (Sigma, St. Louis,
MO) containing 2% FCS, 0.3% bovine pituitary extract
(Cambrex Bio Science Walkersville, Inc., Walkersville,
MD), 10 ng/mL 12-O-tetradecanoylphorbol-13-acetate
(TPA), 2 mmol/L CaCl2,5μg/mL insulin, and 0.1 mmol/L
IBMX (Sigma) (Yang et al.: 2005). Melanoma Malme-3 M
cells were cultured in IMDM media containing 20% FBS
and 1% penicillin and streptomycin. The c83-2C, A375,
SK-Mel-28 or SK-Mel-5 cells were cultured in F10,
DMEM, EMEM or AMEM media; each supplied with 5%
FBS, 5% new born bovine sera, and 2% penicillin and
streptomycin. All cells were kept at 37°C in 5% CO2
incubator.
UV radiation and cell treatment
Cells were grown to about 70% confluence and media
was removed completely for UVB and UVC radiation.
For UVA radiation, 5 ml of 1× PBS was added to one
10-cm dish of cells and ice cubes were placed next to
dishes for absorbing the heat generated by UVA. UVC
radiation was performed in a tissue culture hood with
genotoxic UVC lamp (peak wavelength 254 nm). UVB
radiation was performed in a Stratagen crosslinker with
peak wavelength at 312 nm; and UVA radiation was
also performed in a Stratagen crosslinker with lamps
with peak wavelength at 350 nm. The UV intensity was
measured by a radiometer with proper probes. The cul-
ture media was returned to cells after radiation and cells
were returned to 37°C incubator for recovering. For
kinase inhibitor treatment, inhibitors were added into
culture media 20 minutes before radiation; cells
Figure 7 MiTF mediates signal transduction from Erk1/2 to
p21
WAF1/CIP1 after UVC and ROS stress. UVC and ROS trigger
Erk1/2 activation, which leads to MiTF phosphorylation and
degradation, and enables a temporary G1 cell cycle arrest and
subsequent cell survival.
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ment. Culture media were then removed and cells were
exposed to UVR. Fresh media was added into irradiated
cells without further washing to leave residue kinase
inhibitors in the media.
DNA constructs and lentivirus transduction
Wild-type MiTF cDNA was cloned into expression vec-
tor QCXIP (Clontech, Mountain View, CA) via EcoR I
and Apa I sites. MiTF-S73A mutant was a gift from Dr.
David Fisher (Harvard Medical School, MA), and was
also cloned into QCXIP vector via the same restriction
enzyme sites. MiTF-S409A mutant was generated using
site-directed mutagenesis kit from Stratagen following
the manufacturer’s instruction, with the following
primers: S409-r, 5′-TCCGTC TCTTCC ATGCTC
ATAGCG CTCCTC CGGCTG CTTGTT-3′, and S409-
f, 5′-AACAAG CAGCCG GAGGAG CGCTAT GAG-
CAT GGAAGA GAC GGA-3′. All mutations were con-
firmed by DNA sequencing. The QCXIP-GFP vector
was generated by ligating GFP coding sequence from
pEGFP-N1 (Nhe I and BamH I fragment) into the
BamH I site on QCXIP vector. The p21
WAF1/CIP1 pro-
moter construct (pWWP-Luc, containing about 2.4 kb
promoter region) was a kind gift from Dr. Wafik El-
Deiry (University of Pennsylvania). The Mish1 and
Mish2 shRNA plasmids were purchased from Open Bio-
systems. These plasmids were co-transfected with
pMD2G and pSPAX2 plasmids into 293T cells for virus
production http://tronolab.epfl.ch/. Transduction was
performed in the presence of 10 μg/ml of protamine,
using the filtered 293T media as virus source.
Flow-cytometry and cell cycle analysis
Cells were trypsinized and washed once with 1× PBS,
fixed in cold 70% ethanol overnight or until use. Cells
were incubated in Propidium Iodide (PI) staining solu-
tion in dark for 30 minutes: 50 μg/ml PI, 0.1% sodium
citrate, 50 μg/ml RNase A, 0.03% NP-40 in 1× PBS.
10,000 total events were counted for each sample. Cell
populations from each phase were calculated according
to CellQuest instructions (BD Biosciences).
Cell lysate and western blot analysis
Cell pellet was lysed in a lysis 250 buffer [40] and quan-
tified by the Bradford protein assay method (Bio-Rad,
Richmond, CA). Western blot was performed using
antibodies against MiTF C5 plus D5 (MS-773-P, Lab
V i s i o n ,F r e m o n t ,C A ) ,p 2 1( S a n t aC r u z ) ,p 2 7( S a n t a
Cruz), p53 DO-1 (Santa Cruz), p84 (Abcam, Cambridge,
MA) and a-tubulin (T9026, Sigma, St. Louis, MO), ubi-
quitin (ab7780, Abcam). All western blots were repeated
at least twice, one representative blot is shown in
figures.
Quantitative Real Time RT-PCR and promoter reporter
analysis
One microgram of total RNA isolated from cells was
used for first-strand DNA synthesis with random pri-
mers. One-twentieth of the total cDNA was subjected to
real time PCR amplification in an iCycler iQ5 Real Time
PCR Instrument using iQ SYBR Green Supermix from
Bio-Rad (170-8882). For the a-tubulin and p21
CIP1/WAF1
cDNAs, we used primers AT1 (5′-GCG TGA TGG
TGG GCA TGG GTC AG-3′)a n dA T 2( 5 ′-AGG GGG
GCC TCG GTC AGC AGC AC-3′)a n dp r i m e r sp 2 1 - f
(5′-GAA GAA GGG TAG CTG GGG CT -3′) and p21-r
(5′-CTC TAA GGT TGG GCA GGG TG -3), respec-
tively. The primers For MiTF were mi6a (5′-CCA ACC
GGC ATT TGT TGC TCA-3′) and mi2b (5′-GTT GTT
GAA GGT GAT GGT GCC-3′). Promoter reporter ana-
lysis was carried out using dual luciferase assay system
from Promega. Renilla luciferase driven by SV40 early
promoter (pSV40-RL) was used as an internal control.
Immunofluorescence
Cells were seeded on cover slips and treated as indi-
cated, then fixed in 4% formaldehyde solution in 1× PBS
at room temperature for 30 minutes. After three washes
in 1× PBS, cells were treated with 0.05% Saponin at
room temperature. Cells were washed in 1× PBS again
for 3 times, and incubated with 10% normal goat serum
for 1 hour at room temperature. Cells were further
incubated with primary antibody C5 (1:50 dilution in
10% goat serum) at 4°C overnight. After 5 brief wash
with 1× PBS plus 0.01% NP-40, cells were incubated
with Texas-Red labeled anti-mouse secondary antibody
in dark for 1 hour at room temperature. 1 μg/ml DAPI
was added into staining solution at the last 10 minutes
of incubation for the secondary antibody. Cells were
then washed and mounted to a slide for viewing under a
Zeiss fluorescence microscope.
Colony formation assay
Cells were irradiated and then returned to incubator
with fresh media. Culture media was changed every
three days for 2 weeks. Plates were stained with 0.5%
crystal violet solution in 25% methanol. Only colonies
with more than 50 cells were counted.
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